Showing results (121-130 of 144) with videos related to

Sort By:
Pageof 15
Journal of Clinical Pharmacy and Therapeutics|January 17, 2015
EPICC study: evaluation of pharmaceutical intervention in cancer careN Vantard, F Ranchon, V Schwiertz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 16, 2010
Predictive values of hCG clearance for risk of methotrexate resistance in low-risk gestational trophoblastic neoplasiasB You, M Pollet-Villard, L Fronton, et al.
Journal of Clinical Pharmacy and Therapeutics|October 21, 2014
SIMMEON-Prep study: SIMulation of Medication Errors in ONcology: prevention of antineoplastic preparation errorsL Sarfati, F Ranchon, N Vantard, et al.
Journal of Neurochemistry|April 1, 1996
On the origin of extracellular glutamate levels monitored in the basal ganglia of the rat by in vivo microdialysisM Herrera-Marschitz, Z B You, M Goiny, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 13, 2024
Chemotherapy is not needed when complete evacuation of gestational choriocarcinoma leads to hCG normalizationPa Bolze, S Schoenen, M Margaillan, et al.
Lancet (London, England)|August 25, 1999
6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study Group. DIminution de la Transmission Mère-EnfantF Dabis, P Msellati, N Meda, et al.
Scientific Reports|September 8, 2016
Depinning of domain walls in permalloy nanowires with asymmetric notchesY Gao, B You, X Z Ruan, et al.
Journal of Gynecology Obstetrics and Human Reproduction|December 1, 2023
Impact of molecular genotyping on the diagnosis and treatment of human chorionic gonadotropin-producing tumorsM Peyle, M Massoud, S Patrier, et al.
British Journal of Cancer|January 11, 2017
Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I-type II study from the GINECO groupP-E Heudel, M Fabbro, C Roemer-Becuwe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 8, 2016
A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1)H Bonnefoi, T Grellety, O Tredan, et al.
Pageof 15